Barclays raised its price recommendation on Baxter International stock.
1 report, 1 independent
Updated Jun 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Barclays raised its price recommendation on Baxter International stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Barclays
British bank
- QinetiQ carried out share purchases and arranged for a share buyback execution on the London Stock Exchange.
- Financial institutions provided ratings on multiple companies on July 8, 2026, including Goldman Sachs reiterating Tesla as neutral, Barclays initiating Toast as overweight, and Bank of America rating Nvidia as a buy.
-
Baxter International
American manufacturer of healthcare goods
Nothing else this week.
Related events
- Barclays raised its price target on Latham Group on September 1, 2026.
- Morgan Stanley reaffirmed an overweight rating on AbbVie, and Barclays raised its price objective on September 10, 2026.
- Barclays maintained Overweight rating and raised price target on August 29, 2025.
- Barclays boosted its price target on Bunge on August 16, 2026.
- Barclays issued rating and price objective reports for Ubiquiti on August 1, 2026.